DISHMAN CARBOGEN AMCIS
Back to Cashflow Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹250 Cr | ₹130 Cr | ₹-11 Cr | ₹-98 Cr |
What is the latest Cash Flow from Financing Activities ratio of DISHMAN CARBOGEN AMCIS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹250 Cr |
Mar2022 | ₹130 Cr |
Mar2021 | ₹-11 Cr |
Mar2020 | ₹-98 Cr |
How is Cash Flow from Financing Activities of DISHMAN CARBOGEN AMCIS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹250 Cr | 91.52 | |
Mar2022 | ₹130 Cr | Positive | |
Mar2021 | ₹-11 Cr | Negative | |
Mar2020 | ₹-98 Cr | - |
Compare Cash Flow from Financing Activities of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹4,122.3 Cr | 2.1% | 0.9% | 52% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | 2.1% |
0.9% |
52% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses